Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05444335 · ClinicalTrials.gov registry record · NA
Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years
A NA study of Atrial Fibrillation New Onset, sponsored by University of Maryland, Baltimore.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05444335: Active NA study of Atrial Fibrillation New Onset, sponsored by University of Maryland, Baltimore.
NCT05444335 is a NA study of Atrial Fibrillation New Onset that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 120 participants, below the 267-participant average among 3 other Atrial Fibrillation New Onset trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05444335, a NA study of Atrial Fibrillation New Onset, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Screening for Atrial Fibrillation in Elderly Women (SAFE-W) is a pilot study evaluating the prevalence of atrial fibrillation (Afib) in a rapidly aging segment of the population. Studies have shown that women with Afib are more likely to be symptomatic, have increased mortality from stroke resulting from Afib, and are less likely to receive treatment for Afib. University of Maryland Department of Neurology and Vascular Neurology are recruiting women older than 70 years of age to participate in the study.
Primary Outcome
Percentage of women older than 70 found to have atrial fibrillation one year from enrollment
Conditions Studied
Interventions
- DEVICE Wearable cardiac monitor -Zio patch
Study Locations (1)
Maryland
- University of Maryland Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-07-15 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
What the registry record for NCT05444335 still lists
NCT05444335 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 267-participant average among 3 other Atrial Fibrillation New Onset trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Atrial Fibrillation New Onset appearing as the primary indexed condition, and to 1 intervention - of which Wearable cardiac monitor -Zio patch is the first listed.
NCT05444335 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05444335 about?
NCT05444335 is a clinical study titled "Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years". Screening for Atrial Fibrillation in Elderly Women (SAFE-W) is a pilot study evaluating the prevalence of atrial fibrillation (Afib) in a rapidly aging segment of the population. Studies have shown that women with Afib are more likely to be symptomatic, have increased mortality from stroke resulting...
What is the current status of trial NCT05444335?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-07-15. Estimated completion is 2026-12-15.
What conditions does trial NCT05444335 study?
This clinical trial studies the following conditions: Atrial Fibrillation New Onset.
What interventions are being tested in trial NCT05444335?
The interventions under investigation include: Wearable cardiac monitor -Zio patch (DEVICE).
Who is sponsoring clinical trial NCT05444335?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05444335 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation New Onset
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Screening for Atrial Fibrillation With Self Pulse Monitoring
COMPLETED · NA
-
STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
COMPLETED · NA
-
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI